Magic mushroom compound psilocybin shows ‘promise’ in depression
Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting
Read Moreby Lucy Parsons | Apr 15, 2021 | News | 0
Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting
Read Moreby Selina McKee | Sep 3, 2020 | News | 0
NICE has concerns with the evidence submitted but Janssen insists the nasal spray is a cost-effective use of NHS resources
Read Moreby Anna Smith | Jan 16, 2020 | News | 0
The J&J division seeks to expand the use to adults with major depressive disorder who have current suicidal ideation with intent.
Read Moreby Anna Smith | Sep 20, 2019 | News | 0
The findings support the prescription of SSRI antidepressants in a wider group of participants than previously thought.
Read Moreby Anna Smith | Aug 30, 2019 | News | 0
The team ultimately found that “people with stronger white matter connections in their brain had better improvement with stimulation.”
Read Moreby Anna Smith | Jul 31, 2019 | News | 0
It has also announced the appointment of the company’s new general manager, Craig Bowen.
Read Moreby Anna Smith | May 31, 2019 | News | 0
The governing body has been urged to undergo a “full and proper revision” of its 2009 guideline on adult depression.
Read Moreby Selina McKee | Mar 7, 2019 | News | 0
Allergan’s rapastinel has failed to hit its primary endpoints in three late-stage studies assessing its potential as an adjunctive treatment for depression.
Read Moreby Anna Smith | Mar 7, 2019 | News | 0
The FDA has approved Johnson & Johnson’s Spravato for treatment-resistant depression, offering patients the first new treatment option in several years.
Read Moreby Anna Smith | Feb 13, 2019 | News | 0
FDA advisory committees have jointly voted in favour of approving Janssen’s Spravato nasal spray CIII for adults living with treatment-resistant depression.
Read Moreby Anna Smith | Feb 12, 2019 | News | 0
A new study has found that 10% of adults aged over 75 have major depressive disorder, and over one third sub-threshold depressive symptoms.
Read Moreby Anna Smith | Feb 7, 2019 | News | 0
More than 100 independent variants and 269 genes have been linked to depression by scientists in Edinburgh.
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479